Published date: 2 February 2023
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Research services - 73110000
Location of contract
Any region
Value of contract
£172,782
Procurement reference
tender_304962/1175318
Published date
2 February 2023
Closing date
12 October 2022
Closing time
3pm
Contract start date
5 December 2022
Contract end date
4 December 2024
Contract type
Service contract
Procedure type
Call-off from a framework agreement
A mini-competition or direct purchase from a pre-established framework agreement.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
Yes
Description
"From Harm to Hope" is a cross-government high profile 10-year plan to reduce overall use of drugs. Different departments (Home Office, MoJ, DWP, DHSC, DfE and DLUHC) have made significant commitments in response to the Independent Review of Drugs led by Dame Carol Black. The Drugs Strategy commits the whole of government and our public services to work together to reduce crime and mortality associated with drug supply and misuse.
For HMPPS this means:
- developing the capability and technology to disrupt the supply and use of drugs in prison protecting prisons from being 'academies' of crime.
- making sure that treatment is available so prisoners can make lasting change towards a drug-free life.
HMPPS spends ~£4.5m on mandatory drug testing (MDT) in prisons each year (excluding staff time).
More information
Award information
Awarded date
25 January 2023
Contract start date
5 December 2022
Contract end date
4 December 2024
Total value of contract
£172,782
This contract was awarded to 1 supplier.
RAND Europe Community Interest Company
Address
Westbrook Centre, Milton Road, Cambridge. CB4 1YG. United Kingdom
Reference
Companies House number: 2728021
Supplier is SME?
No
Supplier is VCSE?
No
About the buyer
Address
5 Wellington Place
Leeds
LS1 4AP
England
Share this notice
Closing: 12 October 2022, 3pm
All content is available under the
